FDA Adverse Event Injury Summary report: N

AVAULTA SOLO POSTERIOR SYNTHETIC SUPPORT SYSTEM

MDR report key: 3113598 · Received May 9, 2013

Report

Report Number
1018233-2013-01858
Event Type
Injury
Date Received
May 9, 2013
Report Date
March 15, 2016
Manufacturer
BARD SHANNON LIMITED
Product Code
FTL
PMA / PMN Number
K082571
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
ATTORNEY
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTION FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE REACTIONS: "POTENTIAL ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING HEMATOMA, SEROMA, MUCOSAL OR VISCERAL EROSION, INFECTION, INFLAMMATION, SENSITIZATION, DYSPAREUNIA, SCARIFICATION AND CONTRACTION, FISTULA FORMATION, EXTRUSION AND RECURRENCE OF VAGINAL WALL PROLAPSE. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, RECTUM OR ANY VISCERA MAY OCCUR DURING NEEDLE PASSAGE." (B)(4).

Description of Event or Problem · 1

THE PT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADD'L INFO HAS BEEN REQUESTED, BUT NOT YET REC'D.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
202602 AVAULTA SOLO POSTERIOR SYNTHETIC SUPPORT SYSTEM Mesh, surgical, polymeric FTL BARD SHANNON LIMITED NA HUSL0148

Patients

Seq Age Sex Outcome Treatment
1 74 YR Female Required Intervention